QYResearch Reviewed: Global market of BCG Vaccine developed rapidly, with an average growth rate of 5.74%
More Info: http://www.qyresearchglobal.com/goods-675811.html QYR disclosed a new report-- 2017 Market Research Report on Global BCG Vaccine Industry. The 2017 Market Research Report on Global BCG Vaccine Industry is a professional and in-depth study on the current state of the BCG Vaccine market.
More Info: http://www.qyresearchglobal.com/goods-675811.html QYR disclosed a new report-- 2017 Market Research Report on Global BCG Vaccine Industry. The 2017 Market Research Report on Global BCG Vaccine Industry is a professional and in-depth study on the current state of the BCG Vaccine market.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>QYResearch</strong> <strong>Reviewed</strong>: <strong>Global</strong> <strong>market</strong> <strong>of</strong><br />
<strong>BCG</strong> <strong>Vaccine</strong> <strong>developed</strong> <strong>rapidly</strong>, <strong>with</strong> <strong>an</strong><br />
<strong>average</strong> <strong>growth</strong> <strong>rate</strong> <strong>of</strong> <strong>5.74%</strong><br />
QYRESEARCH FOCUS ON MARKET SURVEY AND RESEARCH<br />
www.qyresearch.com
Beijing Hengzhou Bozhi International<br />
Information Consulting<br />
Web: qyresearchglobal.com | qyresearcheurope.com |<br />
qyresearch.com | qyresearch.com/english |<br />
qyresearchjap<strong>an</strong>.com<br />
TEL:+86-13660489419, Office:+86-2086655165<br />
Media: press@qyresearch.com<br />
Marketing: sales@qyresearch.com<br />
Facebook: @<strong>QYResearch</strong>Official,<br />
Twitter: @<strong>QYResearch</strong>_<br />
Wechat Official Account: <strong>QYResearch</strong>, Weibo: 恒 州 博 智<br />
www.qyresearch.com
<strong>QYResearch</strong><br />
<strong>BCG</strong> <strong>Vaccine</strong> is a vaccine primarily used against<br />
tuberculosis. Tuberculosis is a serious infection,<br />
which affects the lungs <strong>an</strong>d sometimes other parts<br />
<strong>of</strong> the body, such as the bones, joints <strong>an</strong>d kidneys.<br />
The bacille Calmette-Guérin (<strong>BCG</strong>) vaccine has<br />
existed for 80 years <strong>an</strong>d is one <strong>of</strong> the most widely<br />
used <strong>of</strong> all current vaccines, reading >80%<strong>of</strong><br />
neonates <strong>an</strong>d inf<strong>an</strong>ts in countries where it is part <strong>of</strong><br />
the national childhood immunization programme.<br />
Besides, <strong>BCG</strong> <strong>Vaccine</strong> is also used to treat a certain<br />
type <strong>of</strong> bladder c<strong>an</strong>cer. Bladder c<strong>an</strong>cer is the<br />
<strong>growth</strong> <strong>of</strong> abnormal or c<strong>an</strong>cerous cells on the inner<br />
lining <strong>of</strong> the bladder wall. <strong>BCG</strong> helps prevent the<br />
c<strong>an</strong>cer from coming back in the bladder lining, <strong>an</strong>d<br />
also reduces the risk <strong>of</strong> it becoming invasive.<br />
www.qyresearch.com
<strong>QYResearch</strong><br />
According to <strong>QYResearch</strong>, In the last several years, <strong>Global</strong> <strong>market</strong> <strong>of</strong> <strong>BCG</strong> <strong>Vaccine</strong><br />
<strong>developed</strong> <strong>rapidly</strong>, <strong>with</strong> <strong>an</strong> <strong>average</strong> <strong>growth</strong> <strong>rate</strong> <strong>of</strong> <strong>5.74%</strong>. In 2016, <strong>Global</strong> revenue<br />
<strong>of</strong> <strong>BCG</strong> <strong>Vaccine</strong> is about 261.43 M USD. The global <strong>average</strong> gross margin <strong>of</strong> <strong>BCG</strong><br />
<strong>Vaccine</strong> is in <strong>an</strong> decreasing trend, from 71.59% in 2012 to 69.46% in 2017. With<br />
the situation <strong>of</strong> global economy, gross margin will be in decreasing trend in the<br />
following five years.<br />
The type <strong>of</strong> <strong>BCG</strong> <strong>Vaccine</strong> includes Immune <strong>BCG</strong> <strong>an</strong>d Therapy <strong>BCG</strong>. The proportion <strong>of</strong><br />
Therapy <strong>BCG</strong> in 2016 is about 92.73%.<br />
<strong>BCG</strong> <strong>Vaccine</strong> is widely used in Hospitals <strong>an</strong>d Clinics. The most proportion <strong>of</strong> <strong>BCG</strong><br />
<strong>Vaccine</strong> is sold in Hospitals <strong>an</strong>d the <strong>market</strong> share in 2016 is about 74.14%, <strong>an</strong>d the<br />
Hospitals have upstream trend.<br />
www.qyresearch.com
<strong>QYResearch</strong><br />
North America is the largest supplier<br />
<strong>of</strong> <strong>BCG</strong> <strong>Vaccine</strong>, <strong>with</strong> a production<br />
<strong>market</strong> share nearly 32.58% in 2016.<br />
Europe is the second largest supplier <strong>of</strong><br />
<strong>BCG</strong> <strong>Vaccine</strong> Media, enjoying production<br />
<strong>market</strong> share nearly 29.74% in 2016.<br />
North America region is the largest<br />
consumption <strong>of</strong> <strong>BCG</strong> <strong>Vaccine</strong>, <strong>with</strong> a<br />
sales revenue <strong>market</strong> share nearly<br />
36.40% in 2016. Europe is the second<br />
largest consumer <strong>of</strong> <strong>BCG</strong> <strong>Vaccine</strong>,<br />
enjoying sales revenue <strong>market</strong> share<br />
about 32.43% in 2016.<br />
www.qyresearch.com<br />
www.qyresearch.com
<strong>QYResearch</strong><br />
Market competition is not intense.<br />
Merck, S<strong>an</strong><strong>of</strong>i Pasteur, Jap<strong>an</strong> <strong>BCG</strong><br />
Lab, China National Biotec, Serum<br />
Institute <strong>of</strong> India, Intervax,<br />
GSBPL are the leaders <strong>of</strong> the<br />
industry, <strong>an</strong>d they have been<br />
formed in the monopoly position in<br />
the industry.<br />
www.qyresearch.com
Change language